Larson Financial Group’s Zenas BioPharma ZBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBIO
Larson Financial Group's ZBIO Position: Q3 2026 in Review
Larson Financial Group increased its Zenas BioPharma (ZBIO) stake by 20% in Q3 2026, buying an estimated $2.8K and bringing the position to 545 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2296.
Larson Financial Group first reported a position in ZBIO in Q4 2025 and has held it in 4 quarters since. 153 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.
- Larson Financial Group held 545 shares of Zenas BioPharma worth $14.7K as of Q3 2026.
- Larson Financial Group bought 91 Zenas BioPharma shares in Q3 2026, an estimated $2.8K.
- Zenas BioPharma made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2296 holding.
- Larson Financial Group first reported a position in Zenas BioPharma in Q4 2025 and has held it in 4 quarters since.
- 153 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.